PQX1:F Biotage AB (publ)

EUR 15.56 0.00 0
Icon

Biotage AB (publ) (PQX1:F) Stock Analysis and Price Targets

COMMON STOCK | Medical Instruments & Supplies | F
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

EUR 15.56

0.00 (0.00)%

EUR 0.85B

4.00

N/A

N/A

Icon

PQX1:F

Biotage AB (publ) (EUR)
COMMON STOCK | F
EUR 15.56
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

EUR 0.85B

N/A

EUR 15.56

Biotage AB (publ) (PQX1:F) Stock Forecast

N/A

Based on the Biotage AB (publ) stock forecast from 0 analysts, the average analyst target price for Biotage AB (publ) is not available over the next 12 months. Biotage AB (publ)’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Biotage AB (publ) is Slightly Bullish , which is based on 8 positive signals and 6 negative signals. At the last closing, Biotage AB (publ)’s stock price was EUR 15.56. Biotage AB (publ)’s stock price has changed by -2.26% over the past week, +27.54% over the past month and +10.04% over the last year.

No recent analyst target price found for Biotage AB (publ)
No recent average analyst rating found for Biotage AB (publ)

Company Overview Biotage AB (publ)

Biotage AB (publ) provides solution and product in the areas of drug discovery and development, analytical testing, and water and environmental testing. The company offers organic and peptide synthesis solutions; flash chromotherapy, evaporation, and work-up products; flash syste...Read More

https://www.biotage.com

Box 8, Uppsala, Sweden, 751 03

689

December

EUR

Germany

Adjusted Closing Price for Biotage AB (publ) (PQX1:F)

Loading...

Unadjusted Closing Price for Biotage AB (publ) (PQX1:F)

Loading...

Share Trading Volume for Biotage AB (publ) Shares

Loading...

Compare Performance of Biotage AB (publ) Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for PQX1:F

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Biotage AB (publ) (Sector: Medical Instruments & Supplies )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
IUI1:F
Intuitive Surgical Inc 0.00 (0.00%) EUR91.59B 64.59 43.34

ETFs Containing PQX1

Symbol Name PQX1's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Biotage AB (publ) (PQX1:F) Stock

Stock Target Advisor's fundamental analysis for Biotage AB (publ)'s stock is Slightly Bullish .

PQX1:F stock's dividend yield is 1.36%. Our analysis grades PQX1:F stock's dividend yield at F. This means that PQX1:F stock's dividend yield is above 49% of the stocks in the Medical Instruments & Supplies sector in the F exchange. Based on this PQX1:F may be a average dividend stock for its sector.

Unfortunately we do not have enough data on PQX1:F's stock to indicate what its average analyst target is.

PQX1:F stock's Price/Earning ratio is 45.30. Our analysis grades PQX1:F stock's Price / Earning ratio at F. This means that PQX1:F stock's Price/Earning ratio is above 71% of the stocks in the Medical Instruments & Supplies sector in the F exchange. Based on this PQX1:F may be a overvalued for its sector.

The last closing price of PQX1:F's stock was EUR 15.56.

The most recent market capitalization for PQX1:F is EUR 0.85B.

Unfortunately we do not have enough analyst data on PQX1:F's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Biotage AB (publ)'s stock.

As per our most recent records Biotage AB (publ) has 689 Employees.

Biotage AB (publ)'s registered address is Box 8, Uppsala, Sweden, 751 03. You can get more information about it from Biotage AB (publ)'s website at https://www.biotage.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...